Fabio Fuligni
Toronto, ON M4B1B3, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Myeloproliferative Neoplasm Driven by ETV6-ABL1 in an Adolescent with Recent History of Burkitt Leukemia.
Journal: Current oncology (Toronto, Ont.)
Published: May 02, 2023
Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis.
Journal: Cancers
Published: February 02, 2023
Widespread hypertranscription in aggressive human cancers.
Journal: Science advances
Published: November 23, 2022
PD-1 and PD-L1 expression in mycosis fungoides and Sézary Syndrome.
Journal: Italian journal of dermatology and venereology
Published: April 04, 2022
Diverse Oncogenic Fusions and Distinct Gene Expression Patterns Define the Genomic Landscape of Pediatric Papillary Thyroid Carcinoma.
Journal: Cancer research
Published: March 10, 2021
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis.
Journal: Nature communications
Published: February 28, 2021
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib.
Journal: Frontiers in oncology
Published: February 25, 2021
MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma.
Journal: Hematological oncology
Published: January 06, 2021
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival.
Journal: Nature communications
Published: August 26, 2020
TERT promotor variant associated with poor clinical outcome in a patient with novel RBM15-MKL1 fusion-positive pediatric acute megakaryoblastic leukemia.
Journal: Pediatric blood & cancer
Published: May 30, 2020
Last Updated: 09/26/2026